BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30721797)

  • 1. Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors.
    Mansuet-Lupo A; Barritault M; Alifano M; Janet-Vendroux A; Zarmaev M; Biton J; Velut Y; Le Hay C; Cremer I; Régnard JF; Fournel L; Rance B; Wislez M; Laurent-Puig P; Herbst R; Damotte D; Blons H
    J Thorac Oncol; 2019 May; 14(5):844-856. PubMed ID: 30721797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-Generation Sequencing: A Novel Approach to Distinguish Multifocal Primary Lung Adenocarcinomas from Intrapulmonary Metastases.
    Patel SB; Kadi W; Walts AE; Marchevsky AM; Pao A; Aguiluz A; Mudalige T; Liu Z; Deng N; Lopategui J
    J Mol Diagn; 2017 Nov; 19(6):870-880. PubMed ID: 28866070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-generation sequencing facilitates differentiating between multiple primary lung cancer and intrapulmonary metastasis: a case series.
    Liu C; Liu C; Zou X; Shao L; Sun Y; Guo Y
    Diagn Pathol; 2021 Mar; 16(1):21. PubMed ID: 33706781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastases.
    Belardinilli F; Pernazza A; Mahdavian Y; Cerbelli B; Bassi M; Gradilone A; Coppa A; Pignataro MG; Anile M; Venuta F; Della Rocca C; Giannini G; d'Amati G
    Pathol Res Pract; 2021 Apr; 220():153387. PubMed ID: 33647865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman.
    Bonanno L; Calabrese F; Nardo G; Calistri D; Tebaldi M; Tedaldi G; Polo V; Vuljan S; Favaretto A; Conte P; Amadori A; Rea F; Indraccolo S
    Lung Cancer; 2016 Jun; 96():52-5. PubMed ID: 27133750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted deep sequencing helps distinguish independent primary tumors from intrapulmonary metastasis for lung cancer diagnosis.
    Liu J; Mao G; Li Y; Tao L; Wang W; Peng X; Wang J; Li X; Luan X; Luo R; Huang T; Zhang J; Xu M; Chen S; Wu D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2359-2367. PubMed ID: 32333141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Profiling With Large-Scale Next-Generation Sequencing Panels Distinguishes Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases.
    Yang CY; Yeh YC; Wang LC; Lin YY; Lin SY; Wang SY; Chu PY; Liu ZY; Su YC; Ho HL; Chou TY
    Mod Pathol; 2023 Mar; 36(3):100047. PubMed ID: 36788096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas.
    Ezer N; Wang H; Corredor AG; Fiset PO; Baig A; van Kempen LC; Chong G; Issac MSM; Fraser R; Spatz A; Riviere JB; Broët P; Spicer J; Camilleri-Broët S
    Cancer Treat Res Commun; 2021; 29():100484. PubMed ID: 34773797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel NGS-based diagnostic algorithm for classifying multifocal lung adenocarcinomas in pN0M0 patients.
    Zhang X; Fan X; Sun C; Wang L; Miao Y; Wang L; Yang P; Xu Y; Ren X; Wu X; Xu S
    J Pathol Clin Res; 2023 Mar; 9(2):108-120. PubMed ID: 36579550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination of multiple primary lung cancers from intrapulmonary metastasis based on the expression of four cancer-related proteins.
    Ono K; Sugio K; Uramoto H; Baba T; Ichiki Y; Takenoyama M; Hanagiri T; Oyama T; Yasumoto K
    Cancer; 2009 Aug; 115(15):3489-500. PubMed ID: 19452548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic lung cancer subtype differentiates synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases.
    Cheng H; Lei BF; Peng PJ; Lin YJ; Wang XJ
    J Surg Res; 2017 May; 211():215-222. PubMed ID: 28501120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does histological assessment accurately distinguish separate primary lung adenocarcinomas from intrapulmonary metastases? A study of paired resected lung nodules in 32 patients using a routine next-generation sequencing panel for driver mutations.
    Bruehl FK; Doxtader EE; Cheng YW; Farkas DH; Farver C; Mukhopadhyay S
    J Clin Pathol; 2022 Jun; 75(6):390-396. PubMed ID: 33649140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metachronous primary lung adenocarcinomas harboring distinct KRAS mutations.
    Hu Y; Ren S; Chen C; Liang Q; Yu F; Liu W
    Thorac Cancer; 2020 Jul; 11(7):2018-2022. PubMed ID: 32415761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjecting appropriate lung adenocarcinoma samples to next-generation sequencing-based molecular testing: challenges and possible solutions.
    Li W; Qiu T; Ling Y; Gao S; Ying J
    Mol Oncol; 2018 May; 12(5):677-689. PubMed ID: 29518290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major challenges in accurate mutation detection of multifocal lung adenocarcinoma by next-generation sequencing.
    Qiu T; Li W; Zhang F; Wang B; Ying J
    Cancer Biol Ther; 2020; 21(2):170-177. PubMed ID: 31651223
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
    Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using molecular characteristics to distinguish multiple primary lung cancers and intrapulmonary metastases.
    Li Z; Lv H; Zhang F; Zhu Z; Guo Q; Wang M; Huang C; Guo L; Meng F; Tian Z
    PeerJ; 2024; 12():e16808. PubMed ID: 38313018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
    Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis.
    Suzuki K; Nagai K; Yoshida J; Yokose T; Kodama T; Takahashi K; Nishimura M; Kawasaki H; Yokozaki M; Nishiwaki Y
    Cancer; 1997 Apr; 79(8):1521-6. PubMed ID: 9118033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
    Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
    J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.